(19)

(11)

EP 4 739 336 A2

(12)

(88) Date of publication A3: 20.02.2025 (43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24740116.9 (22) Date of filing: 04.07.2024

(51) International Patent Classification (IPC):  A61K 38/43(2006.01) C12N 11/02(2006.01) C07K 17/06(2006.01) C12N 11/06(2006.01) (52) Cooperative Patent Classification (CPC): C07K 17/06; C12N 11/02; C12N 11/06; A61K 38/00; A61K 47/6923; A61K 47/6929; C07K 1/1077 (86) International application number: PCT/EP2024/068917 (87) International publication number: WO 2025/008476 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 06.07.2023 EP 23183863 06.07.2023 EP 23183869 06.07.2023 EP 23183875 06.07.2023 EP 23183881 (71) Applicant: Perseo Pharma AG 4132 Muttenz (CH)	(72) Inventors: KRONENBERG, Vanessa 8003 Zürich (CH) SPECIOSO, Gabriele 4303 Kaiseraugst (CH) BRIAND, Manon 5408 Ennetbaden (CH) LAPRÉVOTTE, Emilie 68220 Hegenheim (FR) DUDAL, Yves Victor René 4103 Bottmingen (CH) SHAHGALDIAN, Patrick 68220 Hegenheim (FR) WATSON, John Ashleigh 8880 Walenstadt (CH) (74) Representative: Latscha Schöllhorn Partner AG  Grellingerstrasse 60 4052 Basel 4052 Basel (CH)